Cable One (NYSE: CABO - Get Free Report) and Harte Hanks (NASDAQ: HHS - Get Free Report) are both small-cap communication services companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, risk, valuation, earnings, institutional ownership, analyst recommendations and dividends. Analyst Recommendations This is a breakdown
Harte Hanks, Inc. (NASDAQ: HHS - Get Free Report)'s stock price passed above its two hundred day moving average during trading on Wednesday. The stock has a two hundred day moving average of $2.88 and traded as high as $4.64. Harte Hanks shares last traded at $4.63, with a volume of 53,850 shares trading hands.
CHELMSFORD, MA / ACCESS Newswire / September 15, 2026 / Harte Hanks, Inc. ("Harte Hanks" or the "Company") announced today the expiration of the "Go-Shop Period" set forth in the previously announced Agreement and Plan of Merger with Star Equity Holdings, Inc. ("Star"), dated as of August 14, 2026 (the "Star Merger Agreement"), the receipt of "Acquisition Proposals" (as defined in the Star Merger Agreement), and the Company's provision to Star of the Exempted Party designation notice pursuant to Section 5.3(a) of the Star Merger Agreement. As previously announced, under the terms of the Star Merger Agreement, Star has agreed to acquire Harte Hanks.
The Department of Health and Human Services is planning to appoint deputy commissioners for technology and drugs at the FDA, creating new roles at the agency, CNBC has learned. Like existing deputy commissioner roles, the two new positions would report into Trump's pick for FDA commissioner, Heidi Overton, who still needs to be confirmed by the Senate.
$HAREHOLDER ALERT: The M&A Class Action Firm Announce the Investigation of the Merger - CHMI, VREX, HHS and ARX PR Newswire
Are MITT, ARX, HHS, FULC Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, Aug. 17, 2026
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws
MILWAUKEE, Aug. 14, 2026 /PRNewswire/ -- Ademi LLP is investigating Harte Hanks (NASDAQ: HHS) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with Star Equity. Click here to learn how to join our investigation and obtain additional information or contact us at gademi@ademilaw.com or toll-free: 866-264-3995.
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Harte Hanks, Inc. (NASDAQ: HHS) to Star Equity Holdings, Inc. Under the terms of the proposed transaction, Harte Hanks shareholders may elect to receive either (1) $5.00 in cash for each Harte Hanks share, or (2) 0.50 shares of Star Equity's publicly traded 10% Series A Cumulative Perpetual Preferred Stock for each Harte Hanks share. Halper Sadeh encourages Harte Hanks shareholders to click he.
Transaction Represents an Approximately 100% Premium to Harte Hanks' Unaffected Share Price Harte Hanks Shareholders to Receive 50% Cash and 50% in Star Equity 10% Preferred Stock CHELMSFORD, MA / ACCESS Newswire / August 14, 2026 / Harte Hanks, Inc. (NASDAQ:HHS) ("Harte Hanks" or the "Company") and Star Equity Holdings, Inc. (NASDAQ:STRR)(NASDAQ:STRRP) ("Star Equity") today announced they have entered into a definitive merger agreement under which Star Equity will acquire all outstanding shares of Harte Hanks common stock for $5.00 per share, or $38.4 million in aggregate equity value. The Harte Hanks Board of Directors unanimously approved the transaction and recommends Harte Hanks shareholders vote in favor of the transaction.
